Show simple item record

Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab

dc.contributor.authorFreeman, CLen_US
dc.contributor.authorDixon, Men_US
dc.contributor.authorHoughton, Ren_US
dc.contributor.authorKreuzer, K-Aen_US
dc.contributor.authorFingerle-Rowson, Gen_US
dc.contributor.authorHerling, Men_US
dc.contributor.authorHumphrey, Ken_US
dc.contributor.authorBoettcher, Sen_US
dc.contributor.authorde Costa, CSen_US
dc.contributor.authorIglesias, Ven_US
dc.contributor.authorStilgenbauer, Sen_US
dc.contributor.authorGribben, Jen_US
dc.contributor.authorHallek, Men_US
dc.contributor.authorGoede, Ven_US
dc.date.accessioned2017-11-21T16:37:03Z
dc.date.issued2016en_US
dc.date.submitted2017-01-21T09:29:29.166Z
dc.identifier.issn0887-6924en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/28865
dc.format.extent1763 - 1766en_US
dc.language.isoenen_US
dc.relation.ispartofLEUKEMIAen_US
dc.rightsCC-BY-NC-ND
dc.titleRole of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumaben_US
dc.typeArticle
dc.rights.holder© 2016, Rights Managed by Nature Publishing Group
dc.identifier.doi10.1038/leu.2016.41en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380826400019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue8en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume30en_US
qmul.funderChronic Lymphocytic Leukemia Research Consortium::National Cancer Instituteen_US


Files in this item

Thumbnail
Name:
Freeman Role of CD20 expression ...
Size:
530.5Kb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record